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Abstract
Objective: To determine the effectiveness of oscillating positive expiratory pressure (OPEP) using predetermined 
expiratory pressures on the viscosity and transportability of sputum in patients with bronchiectasis. Methods: The 
study involved 15 stable patients with bronchiectasis (7 males; mean age = 53 ± 16 years), submitted to two 
consecutive OPEP interventions, with a 24-h interval between the two, using positive expiratory pressures set 
at 15 cmH2O (P15) and 25 cmH2O (P25). The protocol consisted of a voluntary cough; another voluntary cough 
20 min later, designated time zero (T0); a 10-min rest period; and two 10-min series (S1 and S2, using OPEP at 
P15 and P25 in both), with a 10-min interval between the two. The viscosity and transportability of sputum were 
evaluated by viscometry, relative transport velocity on frog palate, transport in a simulated cough machine and 
contact angle. Sputum samples were collected at T0, after S1 and after S2. Specific statistical tests were performed 
depending on the type of data distribution. Results: In comparison with the values obtained at T0, sputum 
viscosity decreased significantly after S1 at P15 and after S2 at P25. There were no significant differences among 
all of the samples in terms of transportability. Conclusions: The fact that sputum viscosity decreased whether OPEP 
was performed at P15 or at P25 suggests that there is no need to generate high expiratory pressure to achieve the 
desired result. 
Keywords: Viscosity; Bronchiectasis; Physical therapy (specialty); Sputum.
Resumo
Objetivo: Verificar a efetividade da técnica de pressão expiratória positiva oscilante (PEPO) utilizando pressões 
expiratórias pré-determinadas sobre a viscosidade e a transportabilidade do escarro em pacientes com bron-
quiectasia. Métodos: Foram incluídos no estudo 15 pacientes estáveis com bronquiectasia (7 homens; média de 
idade = 53 ± 16 anos), submetidos a duas intervenções PEPO consecutivas, com 24 h de intervalo entre si, utili-
zando pressões expiratórias de 15 cmH2O (P15) e 25 cmH2O (P25). O protocolo consistiu de tosse voluntária; nova 
expectoração voluntária após 20 min, denominado tempo zero (T0); repouso de 10 min; e utilização da técnica 
em duas séries de 10 min (S1 e S2) de PEPO em P15 e P25, com intervalo de 10 min entre si. A viscosidade e 
transportabilidade do escarro foram avaliadas pela viscosimetria, velocidade relativa de transporte no palato de rã, 
deslocamento em máquina simuladora de tosse e ângulo de adesão. As amostras de escarro foram coletadas em 
T0, após S1 e após S2. Testes estatísticos específicos foram aplicados de acordo com a distribuição dos dados. 
Resultados: Houve diminuição significante da viscosidade do escarro após S1 em P15 e após S2 em P25. Não 
houve diferenças significantes entre todas as amostras para a transportabilidade. Conclusões: Houve diminuição 
da viscosidade do escarro quando a PEPO foi realizada em P15 e P25, o que sugere que não seja necessário gerar 
alta pressão expiratória para obter o resultado desejado.
Descritores: Viscosidade; Bronquiectasia; Fisioterapia (especialidade); Escarro.
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Studies evaluating the clinical use of the 
Flutter VRP1® have demonstrated improvements 
in sputum expectoration,(8) pulmonary function 
and clinical score,(12) as well as in oxygen satura-
tion and blood gas analysis.(13)
Although those clinical studies confirm 
the effectiveness of the use of OPEP, none 
of the physical variables of the Flutter VRP1®, 
such as flow, expiratory pressure and oscilla-
tion frequency, were monitored, and in vitro 
studies(6,14) have demonstrated that these vari-
ables influence the effects generated by the 
equipment. In addition, there have been no 
studies evaluating the influence that the use of 
this device, at different expiratory pressures, has 
on the rheological properties of sputum.
Therefore, the objective of the present study 
was to evaluate the influence that OPEP, using 
the Flutter VRP1® at controlled expiratory pres-
sures (15 and 25 cmH2O), has on the viscosity 
and transportability of sputum.
Methods
The study involved 15 volunteers (7 were 
male) with cylindrical or varicose bronchiectasis 
and treated at the Bronchiectasis Outpatient 
Clinic of the Federal University of São Paulo/
Paulista School of Medicine. None of the 
15 patients had vesicular bronchiectasis.
The participating patients presented the 
following characteristics (in mean ± SD): 
age = 53 ± 16 years; weight = 59 ± 14 kg; height = 
1.58 ± 0.08 m; body mass index = 23 ± 5 kg/m2; 
FEV1/FVC = 63 ± 17%; and FVC = 71.7 ± 13.8%. 
The study participants did not engage in any 
physical activity, nor did they participate in any 
pulmonary rehabilitation program, and only one 
used oxygen therapy.
The experimental procedures were approved 
by the Research Ethics Committee of the 
Faculdade de Ciências e Tecnologia/Universidade 
Estadual Paulista (FCT/UNESP, School of Science 
and Technology/São Paulo State University) in 
the city of Presidente Prudente, located in the 
State of São Paulo, Brazil (Process no. 093/2006). 
All participants were advised of the procedures 
and objectives of the study, and all gave written 
informed consent.
The criteria for inclusion in the study were as 
follows: having no cognitive changes, as deter-
mined by the Mini-Mental State Examination(15); 
being self-stabilized (with constant oral hydra-
Introduction
In chronic suppurative lung diseases, such as 
bronchiectasis, the irreversible bronchial changes 
and the persistent production of purulent 
sputum results, in the long term, in impaired 
defense mechanisms and impaired mucociliary 
clearance, with consequent accumulation of 
secretion in the respiratory tract.(1) Therefore, 
mechanisms that promote the displacement and 
removal of secretions are essential to maintain 
the respiratory tract defenses against infections 
and the proliferation of bacteria.(2)
One of the most important mechanisms to 
promote the removal of secretions consists is 
changing their viscoelastic properties.(3) One 
of the bronchial hygiene techniques employed 
in physical therapy uses the Flutter VRP1® 
(Scandipharm, Birmingham, AL, USA), which 
combines high-frequency oscillation and posi-
tive expiratory pressure, and its proposed effects 
are preventing airway obstruction and removing 
the accumulation of secretion.(4)
The Flutter VRP1® is a device containing a 
cone, within which there is a metallic sphere. 
When the patient exhales through the device, 
the expired airflow raises the metallic sphere, 
which falls again under its own weight. The 
rapid succession of these events makes the 
air vibrate within the device, and this vibra-
tion is transmitted to the patient airways,(5,6) 
displacing the secretion and facilitating expec-
toration.(5) However, it remains unclear whether 
these effects result in changes in the rheological 
properties of sputum.(4)
Studies have confirmed some of the mecha-
nisms of action of this device by analyzing the 
volume of sputum and the spirometric parame-
ters.(7-10) One group of authors,(4) in a pilot study 
of patients with bronchiectasis, evaluated the 
effect that two techniques, one of which being 
oscillating positive expiratory pressure (OPEP), 
have on sputum transportability and found that 
there was no change in transport after the use 
of either technique. Another group of authors,(11) 
in a case study of a patient with bronchiectasis, 
compared the effects of the use of the Flutter 
VRP1® and the use of “tapotement” (percussive 
tapping) on the transportability and viscoelas-
ticity of sputum and concluded that the use of 
the device made sputum less viscous and there-
fore improved transportability.
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interval between the two, in accordance with 
the protocol used in the CEAFIR Department of 
Respiratory Physical Therapy, totaling 20 min of 
exercise, which is in agreement with the tech-
niques used in previous studies.(4,18)
In order to perform the technique, the patients 
were instructed to remain seated on a chair, with 
their torso inclined forward (coxofemoral joint 
flexion at 65°), their head in a neutral position, 
their elbows supported on a table and their hands 
holding the device. When exhaling through the 
device, the patients could change their posi-
tion in terms of torso inclination if they did not 
feel an intrathoracic vibration effect, which was 
confirmed by the therapist. Similarly, in terms 
of the inclination of the device, the patients 
reported the inclination at which (range, −30° to 
+30°)the intrathoracic vibration effect was more 
evident. The posture adopted to perform the 
technique was that in which there was a greater 
intrathoracic air vibration effect, reported by the 
patient and confirmed by the therapist’s hands, 
which were placed on the chest of the patient. 
This practice was repeated in each session.
During or at the end of each series, the 
least aqueous portion of the sputum collected 
at T0 was stored in a plastic Eppendorf tube, 
containing mineral oil to prevent dryness, and 
frozen at −20°C for subsequent analysis, which 
was performed in the FCT/UNESP Laboratory for 
Mucus Secretion System Studies.
For the analysis of the transportability and 
viscosity of sputum, the samples were defrosted 
and submerged in petroleum ether to remove 
the mineral oil. Mucociliary transportability was 
tion); being clinically stable, as determined by 
the absence of fever, the absence of evidence of 
a recent respiratory infection and the constant 
volume/aspect of the secretion; having had 
no changes in drug dosage; and being able to 
perform the technique using the Flutter VRP1® 
at the predetermined expiratory pressures.
In order to measure and record expira-
tory pressures, a mouthpiece was developed to 
connect a vacuum manometer (± 300 cmH2O; 
Gerar, São Paulo, Brazil) to the Flutter VRP1® 
(Figure 1). Before starting the experimental 
protocol, to ensure the reliability of the values 
seen in the vacuum manometer, the manometer 
was connected to a pressure generator (water 
column) in order to determine whether the pres-
sure generated and, consequently, the pressure 
displayed in this equipment were equivalent. In 
addition, the calibration of the vacuum manom-
eter was checked at each collection.
Before performing the technique using pres-
sures set at 15 cmH2O (P15) and 25 cmH2O 
(P25), the participants underwent training, which 
consisted in using the technique until being able 
to perform three consecutive exhalations at the 
predetermined expiratory pressure. By watching 
the vacuum manometer display, the participants 
could maintain the established pressure, which 
was also checked by the therapist.
The choice of P15 was based on the obser-
vation of the results obtained in clinical 
practice at the FCT/UNESP Centro de Estudos 
e Atendimentos em Fisioterapia e Reabilitação 
(CEAFIR, Center for Physical Therapy and 
Rehabilitation Studies and Treatment), in which 
we identified that the mean expiratory pressure 
generated by the patients, when instructed to 
perform the technique using the Flutter VRP1® for 
10 consecutive min, was 15 cmH2O. In contrast, 
P25 was considered since it is described in the 
literature as the maximum expiratory pressure 
obtained using the equipment.(16,17) The selec-
tion of the expiratory pressure to be used on the 
first day of the protocol was made randomly.
The standard technique used on the two days 
of the experiment was as follows: a) a voluntary 
cough to expectorate sputum, so that all partici-
pants would start the experiment under the same 
baseline conditions; b) another voluntary cough, 
after a 20-min rest period, designated time zero 
(T0); c) 10 min after T0, two 10-min series (S1 
and S2) using the Flutter VRP1®, with a 10-min 
Figure 1 - Adaptation to allow the vacuum 
manometer and the Flutter VRP1® to be connected in 
order to measure and record expiratory pressures at 
each exhalation.
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cm and Q = volumetric flow ratio). The mean 
viscosity value, which was obtained by meas-
uring the viscosity of five samples of the same 
sputum that were collected at each time point, 
was used for the analysis.
For statistical analysis, first the Shapiro-Wilk 
test was used to assess the normality of the data. 
For data with normal distribution, the comparison 
between P15 and P25 in terms of the different 
time points (T0, S1 and S2) was performed using 
the Student’s t-test for paired data (simulated 
cough machine, contact angle, relative velocity 
of sputum on frog palate after S1 and viscosity 
after S1). For data with non-normal distribution, 
the Wilcoxon test was used (relative velocity of 
sputum on frog palate at T0 and after S2 and 
analyzed based on relative transport velocity on 
frog palate, sputum transport in a simulated 
cough machine and contact angle.(19)
Relative transport velocity of sputum on 
frog palate (velocity of sputum/velocity of 
endogenous mucus) was measured using a 
stereoscopic magnifying glass equipped with a 
reticulated eyepiece (Wild M8; Wild Heerbrugg, 
Gais, Switzerland) and using a stopwatch (Track.
Pro; Mondaine, Zurich, Switzerland) to measure 
transport time (in seconds) in a cephalocaudal 
direction along 10 mm of frog palate.(20,21) After 
every four samples tested, the frog mucus was 
measured to control the integrity of the palate.
The in vitro representation of cough was 
performed using a simulated cough machine,(22) 
consisting of a simple airway model (a PVC 
tube), measuring 4 mm in internal diameter 
and 30 cm in length, within which the sputum 
samples were placed. This model was connected 
to a latex tube that linked it to a solenoid valve, 
which was connected to a timing system. The 
propellant pressure was 4.2 kgf/cm2, and release 
time was 1 s. In order to perform the test, a small 
quantity of sputum was placed in the proximal 
part of the model and the timing system was 
activated.
In order to measure the contact angle, the 
sputum sample was placed on a deionized slide, 
which was treated with sulfochromic acid, and 
was observed using an eyepiece (×20)equipped 
with a goniometer (angle microscope/042002; 
Holtermann, São Paulo, Brazil). The contact 
angle was measured (in degrees) immediately 
after the sample was placed on the slide and 
5 min later. The angle formed between the 
sputum and the solid surface reflects the surface 
tension and strength of adhesion of sputum.(23)
Viscosity was analyzed using a dual capillary 
viscometer,(24,25) consisting of a steel capillary 
within a glass capillary. The capillary system 
was connected to a water pressure column. A 
quantity of sputum filling 5 mm of the glass 
capillary was placed at its proximal end, which 
was connected to the water pressure column. 
Sputum detachment, pressure, time elapsed 
and recoil were determined by imposing pres-
sure within the capillary. The viscosity value 
was obtained using Poiseuille’s equation 
(η = ϖ × r4 × ΔP/8 × l × Q; where η = viscosity, 
r = tube radius in cm, ΔP = sample pressure 
within the tube in cmH2O, l = tube length in 
Table 1 - Sputum viscosity (×10³ P) for patients with 
bronchiectasis prior to and after the use of the Flutter 
VRP1® with pressures set at 15 and 25 cm H2O.
a
Pressure, 
cmH2O
T0 S1 S2
15 0.83 ± 0.73 
(0.68)*
0.27 ± 0.20 
(0.24)*
0.48 ± 0.58 
(0.30)
[0.43-1.24] [0.16-0.38] [0.16-0.80]
25 0.53 ± 0.47 
(0.44)
0.28 ± 0.18 
(0.23)
0.36 ± 0.41 
(0.26)*
[0.27-0.80] [0.18-0.38] [0.13-0.59]
T0: sputum samples collected after a 20-min rest period; 
S1: sputum samples collected after the 1st series using the 
Flutter VRP1®; and S2: sputum samples collected after the 
2nd series using the Flutter VRP1®. aValues expressed as 
mean ± SD (median) [95% CI]. *Values with a statistically 
significant difference in relation to T0 (Friedman test, 
followed by Dunn’s test; p < 0.05).
Table 2 - Relative transport velocity of sputum on 
frog palate (velocity of sample/normal velocity of frog 
mucus) for patients with bronchiectasis prior to and 
after the use of the Flutter VRP1® with pressures set 
at 15 and 25 cm H2O.
a
Pressure, 
cmH2O
T0 S1 S2
15 0.97 ± 0.43 
(0.87)
0.87 ± 0.26 
(0.82)
0.95 ± 0.37 
(0.83)
[0.74-1.21] [0.72-1.01] [0.75-1.16]
25 0.76 ± 0.20 
(0.75)
0.94 ± 0.40 
(0.84)
0.87 ± 0.30 
(0.72)
[0.65-0.89] [0.72-1.16] [0.71-1.03]
T0: sputum samples collected after a 20-min rest period; 
S1: sputum samples collected after the 1st series using the 
Flutter VRP1®; and S2: sputum samples collected after the 
2nd series using the Flutter VRP1®. aValues expressed as 
mean ± SD (median) [95% CI].
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P25 were significantly lower than were those 
obtained at T0 at each pressure, respectively.
Table 2 presents the mean values for relative 
transport velocity of sputum at each time point 
and at each pressure applied using the device. 
There were no significant differences among 
the time points at each pressure or between the 
pressures studied.
Table 3 shows the mean values for sputum 
transport in a simulated cough machine at the 
different time points and expiratory pressures. 
There were no significant differences among 
the time points analyzed at each pressure or 
between the pressures studied.
Table 4 presents the mean values for sputum 
contact angle. No significant differences were 
found among the time points analyzed or 
between the pressures studied.
Discussion
The results demonstrate that there were 
no significant differences in sputum viscosity 
between the values obtained at T0 (Table 1). The 
absence of differences ensured the similarity of 
sputum viscosity prior to the initiation of each 
intervention. In addition, there were significant 
differences between S1 and T0 at P15, as well 
as between S2 and T0 at P25, and there were 
no differences between the expiratory pressures 
viscosity at the same time points). The compar-
ison of the different time points (T0, S1 and S2) 
in terms of the same expiratory pressure was 
performed using ANOVA with repeated measures 
(simulated cough machine and contact angle 
at P15 and P25) or the Friedman test (relative 
velocity of sputum on frog palate and viscosity 
at P15 and P25), followed by Dunn’s test. The 
level of significance was set at 5%.(26)
The power of the study was calculated using 
the GraphPad StatMate software, version 2.00 
for Windows (GraphPad Software, San Diego, 
CA, USA). The number of volunteers analyzed 
and the level of significance of 5% (two-tailed 
test) ensured a power greater than 80% to detect 
differences among the variables.
Results
None of the patients were excluded from the 
study, and all of them performed the technique 
with the Flutter VRP1® placed in a neutral posi-
tion, that is, parallel to the table. Table 1 shows 
the mean values for sputum viscosity prior to 
(T0) and after (S1 and S2) the sessions performed 
at P15 and P25. It is possible to observe that 
there was no significant difference between 
the values obtained at T0 for the two sessions 
performed (P15 and P25) and that the viscosity 
values obtained after S1 at P15 and after S2 at 
Table 3 - Sputum transport in a simulated cough machine (in mm) for patients with bronchiectasis prior to 
and after the use of the Flutter VRP1® with pressures set at 15 and 25 cm H2O.
a
Pressure, cmH2O T0 S1 S2
15 141.93 ± 50.35
[114.05-169.82]
153.83 ± 52.30
[124.87-182.79]
153.03 ± 53.69
[123.29-182.76]
25 127.21 ± 53.59
[97.54-153.89]
140.93 ± 56.84
[109.46-172.41]
137.33 ± 53.59
[107.65-167.01]
T0: sputum samples collected after a 20-min rest period; S1: sputum samples collected after the 1st series using the Flutter 
VRP1®; and S2: sputum samples collected after the 2nd series using the Flutter VRP1®. aValues expressed as mean ± SD 
[95% CI].
Table 4 - Sputum contact angle (in degrees) for patients with bronchiectasis prior to and after the use of the 
Flutter VRP1® with pressures set at 15 and 25 cm H2O.
a
Pressure, cmH2O T0 S1 S2
15 37.33 ± 6.71 32.47 ± 8.17 37.20 ± 12.31
[33.62-41.05] [27.94-37.00] [30.38-44.02]
25 35.67 ± 9.50 35.93 ± 9.56 35.93 ± 8.65
[30.42-40.92] [30.64-41.23] [31.15-40.72]
T0: sputum samples collected after a 20-min rest period; S1: sputum samples collected after the 1st series using the Flutter 
VRP1®; and S2: sputum samples collected after the 2nd series using the Flutter VRP1®. aValues expressed as mean ± SD 
[95% CI].
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studied or the expiratory pressures used in terms 
of transportability as evaluated using the simu-
lated cough machine. Since expiratory time was 
not controlled, it is not possible to ensure that 
the oscillation frequency was constant enough 
to alter elasticity, a property that was not evalu-
ated in the present study, given that sputum 
clearance depends on a high viscosity/elasticity 
ratio.(28)
In terms of sputum contact angle, there 
were no significant differences among the time 
points analyzed at each pressure or between the 
pressures (Table 4). Assuming that the practices 
performed did not contribute to the worsening 
of the physicochemical properties of sputum, 
that the initial time points of the practices did 
not present statistical differences, that the ideal 
contact angle value was approximately 20°(21) 
and that the sputum samples during those 
sessions presented an angle that differed signifi-
cantly from the reference values, with a mean 
higher than 32°, we can infer that, at all time 
points analyzed, sputum transportability was 
decreased.
The high means for contact angle (Table 4) 
and the low means for relative transport velocity 
on frog palate (Table 2), in comparison with 
the reference values, show that sputum trans-
portability was decreased and, regardless of the 
expiratory pressure employed while using the 
Flutter VRP1®, sputum clearance by the muco-
ciliary system would be more difficult.
The absence of significant differences in 
terms of sputum transportability after the tech-
nique was performed at P15 and at P25 is in 
agreement with the results of one study,(4) 
despite methodological differences related to 
expiratory pressure and time required to perform 
the technique.
In summary, as has been shown in a study 
of patients with cystic fibrosis,(12) the use of 
the Flutter VRP1® is safe, efficient and easy in 
patients with bronchiectasis. Under the condi-
tions of our experiment, the use of the device 
at a controlled expiratory pressure is a viable 
technique that can be implemented in clinical 
practice. It is only necessary to adapt a mouth-
piece so that a vacuum manometer can be 
connected.
In addition, our results showed that there 
were no significant differences in terms of 
sputum transportability at the different pres-
at each time point studied, which suggests that 
the use of the Flutter VRP1® reduced sputum 
viscosity, facilitating sputum clearance, and its 
immediate effect was more evident at P15. This 
finding is in agreement with those of previous 
studies,(3,11) which found decreased sputum 
viscosity with the use of the device.
The occurrence of significant differences in 
sputum viscosity at distinct time points, at the 
expiratory pressures studied, can be related to the 
difference in expiratory time in the two sessions. 
Although expiratory time was not controlled, 
we observed that, at a lower pressure (P15), the 
patients maintained longer expiratory time and, 
consequently, the amount of time to which the 
mucus was exposed to a constant oscillation 
frequency increased, making viscosity decrease 
after only one series. In order to perform the 
technique at P25, a greater effort is needed and 
shorter expiratory time was observed. Therefore, 
the amount of time to which the mucus was 
exposed to oscillation decreased, and the effect 
on sputum viscosity was achieved only after S2.
In the present study, three methods were 
used to evaluate sputum transportability: rela-
tive transport velocity of sputum on frog palate, 
sputum transport in a simulated cough machine 
and contact angle.(21)
In terms of transport velocity on frog palate, 
no significant differences were found after the 
session performed at the two expiratory pres-
sures or among each time point analyzed 
(Table 2). However, the means for relative muco-
ciliary transport velocity were found to be lower 
than 0.97. According to one group of authors,(27) 
a sputum sample with good transportability is 
that presenting relative velocity values between 
1.0 and 1.1. The values found in the present 
study suggest that cough alone, as well as the 
use of OPEP at P15 or at P25, removes sputum 
with decreased transportability, there being no 
influence of the device.
In vitro mucociliary transport was also 
analyzed based on sputum transport in a 
simulated cough machine.(22) Physiologically, 
secretion clearance by cough can be facilitated 
by a high viscosity/elasticity ratio.(28) However, 
sputum samples with extremely high viscoe-
lastic components can present decreased in vitro 
transport,(28) as evaluated using the simulated 
cough machine. In the present study, there were 
no significant differences among the time points 
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sures during the sessions using the device. 
However, the decreased sputum viscosity after 
the sessions at P15 and P25 suggests a better 
rheological profile and greater sputum thinning 
after the use of the device. Due to the similarity 
of the results obtained at the two pressures 
studied, we can conclude that the patient does 
not have to generate high pressure to achieve 
the desired result.
In the present study, expiratory pressure 
measurement (P15 and P 25) was the only vari-
able that was pre-established and controlled 
during the series using the device. Therefore, the 
absence of data regarding expiratory time, flow 
and oscillation frequency can be considered a 
limitation of the present study. For this reason, 
future studies should include the standardiza-
tion of these variables, during the use of the 
device, so that their effect on the rheological 
properties of sputum can be understood more 
fully.
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